Anti-CNTP5/ CNTNAP5/ caspr5 monoclonal antibody

Anti-CNTP5/ CNTNAP5/ caspr5 antibody for FACS & in-vivo assay

Target products collectionGo to CNTNAP5/CNTNAP5 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0321-Ab-1/ GM-Tg-hg-MP0321-Ab-2Anti-Human CNTNAP5 monoclonal antibodyHuman
GM-Tg-rg-MP0321-Ab-1/ GM-Tg-rg-MP0321-Ab-2Anti-Rat CNTNAP5 monoclonal antibodyRat
GM-Tg-mg-MP0321-Ab-1/ GM-Tg-mg-MP0321-Ab-2Anti-Mouse CNTNAP5 monoclonal antibodyMouse
GM-Tg-cynog-MP0321-Ab-1/ GM-Tg-cynog-MP0321-Ab-2Anti-Cynomolgus/ Rhesus macaque CNTNAP5 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0321-Ab-1/ GM-Tg-felg-MP0321-Ab-2Anti-Feline CNTNAP5 monoclonal antibodyFeline
GM-Tg-cang-MP0321-Ab-1/ GM-Tg-cang-MP0321-Ab-2Anti-Canine CNTNAP5 monoclonal antibodyCanine
GM-Tg-bovg-MP0321-Ab-1/ GM-Tg-bovg-MP0321-Ab-2Anti-Bovine CNTNAP5 monoclonal antibodyBovine
GM-Tg-equg-MP0321-Ab-1/ GM-Tg-equg-MP0321-Ab-2Anti-Equine CNTNAP5 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0321-Ab-1/ GM-Tg-hg-MP0321-Ab-2; GM-Tg-rg-MP0321-Ab-1/ GM-Tg-rg-MP0321-Ab-2;
GM-Tg-mg-MP0321-Ab-1/ GM-Tg-mg-MP0321-Ab-2; GM-Tg-cynog-MP0321-Ab-1/ GM-Tg-cynog-MP0321-Ab-2;
GM-Tg-felg-MP0321-Ab-1/ GM-Tg-felg-MP0321-Ab-2; GM-Tg-cang-MP0321-Ab-1/ GM-Tg-cang-MP0321-Ab-2;
GM-Tg-bovg-MP0321-Ab-1/ GM-Tg-bovg-MP0321-Ab-2; GM-Tg-equg-MP0321-Ab-1/ GM-Tg-equg-MP0321-Ab-2
Products NameAnti-CNTNAP5 monoclonal antibody
Formatmab
Target NameCNTNAP5
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CNTNAP5 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species CNTP5/ CNTNAP5/ caspr5 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP0321
    Target NameCNTNAP5
    Gene ID129684,636808,697828,483874,101098396,100336611,100050788
    Gene Symbol and Synonymscaspr5,Caspr5-1,CNTNAP5,Cntnap5a,EG636808
    Uniprot AccessionQ8WYK1,Q0V8T0
    Uniprot Entry NameCNTP5_HUMAN,CNTP5_CANLF
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000155052
    Target ClassificationN/A

    The target: CNTNAP5, gene name: CNTNAP5, also named as caspr5. This gene product belongs to the neurexin family, members of which function in the vertebrate nervous system as cell adhesion molecules and receptors. This protein, like other neurexin proteins, contains epidermal growth factor repeats and laminin G domains. In addition, it includes an F5/8 type C domain, discoidin/neuropilin- and fibrinogen-like domains, and thrombospondin N-terminal-like domains. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.